Results 41 to 50 of about 132,893 (224)

B2-InF Newsletter #3: article from industry

open access: yes, 2022
B2-InF Newsletter #3: article from industry_Article
B2-InF Consortium
core   +1 more source

Individual variation in platelet aggregability and serum thromboxane B2 concentrations after low-dose aspirin.

open access: yes, 1988
The effects of low daily oral doses of aspirin (40 mg/day) on platelet aggregability and serum thromboxane B2 concentrations were studied in 19 poststroke patients.
M Kimura   +4 more
core   +1 more source

Polymorphisms in the bradykinin B2 receptor gene and childhood asthma [PDF]

open access: yes, 2001
Bradykinin has been suggested as one of the key mediators of bronchial asthma. Polymorphisms with a potential functional relevance have been described in the B2 bradykinin receptor gene.
Illi, S.   +11 more
core   +2 more sources

B2-InF Newsletter #3: Next steps

open access: yes, 2022
B2-InF Newsletter #3: article
B2-InF Consortium
core   +1 more source

Urinary leukotriene E4 and 11-dehydro-thromboxane B2 excretion in children with bronchial asthma

open access: yesAllergology International, 2004
Background: Cysteinyl leukotrienes (CysLTs) and thromboxane (TX) A2 have been implicated in the pathogenesis of bronchial asthma. Urinary leukotriene E4 (LTE4) and 11-dehydro-TXB2 (11 DTXB2) levels are often used to assess the production of CysLTs and ...
Kaori Yoshikawa   +9 more
doaj   +1 more source

Safety and Feasibility of Magnetic Separation‐Based Blood Purification

open access: yesAdvanced NanoBiomed Research, EarlyView.
We present the preclinical biological safety and translational feasibility of a magnetic nanoparticle‐based extracorporeal blood purification platform for removal of disease‐causing blood factors. ISO 10993‐compliant studies and exaggerated worst‐case exposure models demonstrate efficient nanoparticle extraction (≥99.9%), favorable biocompatibility ...
Carlos A. Mora   +11 more
wiley   +1 more source

Intravenous infusion of a selective inhibitor of thromboxane A2 synthetase in man: influence on thromboxane B2 and 6-keto-prostaglandin F1 alpha levels and platelet aggregation.

open access: yes, 1984
The effect of the selective thromboxane A2 synthetase inhibitor OKY-1581, a pyridine derivative [sodium (E)-3-(4-(3-pyridylmethyl)phenyl)-2-methyl-2-propenoate], on thromboxane B2 and 6-keto-prostaglandin F1 alpha levels and platelet aggregation was ...
Y Yui   +9 more
core   +1 more source

B2-InF Newsletter #3: Event participation

open access: yes, 2022
B2-InF Newsletter #3: Event participation_article
B2-InF Consortium
core   +1 more source

Circulating levels of cyclooxygenase metabolites in experimental Trypanosoma cruzi infections

open access: yesMediators of Inflammation, 2004
TRYPANOSOMA cruzi induces inflammatory reactions in several tissues. The production of prostaglandin F2α, 6-keto-prostaglandin F1α and thromboxane B2, known to regulate the immune response and to participate in inflammatory reactions, was studied in mice
Rita L. Cardoni, María Inés Antúnez
doaj   +1 more source

Differential Impact of Serial Measurement of Nonplatelet Thromboxane Generation on Long‐Term Outcome After Cardiac Surgery

open access: yesJournal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, 2017
BackgroundSystemic thromboxane generation, not suppressible by standard aspirin therapy and likely arising from nonplatelet sources, increases the risk of atherothrombosis and death in patients with cardiovascular disease.
Nikolaos Kakouros   +6 more
doaj   +1 more source

Home - About - Disclaimer - Privacy